Clinical Trial

Dupilumab Therapy for EGIDs

Name: Dupilumab Therapy for EGIDs — clinical trial record (NCT07257835)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This is a single-center observational study to investigate the efficacy and tolerability of dupilumab in children with refractory eosinophilic gastrointestinal disorders.

Trial Details

NCT Number	NCT07257835
Lead Sponsor	Children's Hospital of Fudan University
Conditions	Eosinophilic Gastrointestinal Disorders (EGIDs)
Enrollment	20 participants
Start Date	2025-01-01
Primary Completion	2027-01-01 (estimated)
Study Completion	2027-12-01 (estimated)
Updated on ClinicalTrials.gov	2025-12-02